Graviti Pharmaceuticals operates in the pharmaceutical and biotechnology sector, focusing on drug development, manufacturing, and distribution of therapeutic products. The company’s portfolio typically spans generics, specialty formulations, and supp...
"I joined as a lab technician two years ago and I have grown a lot. The bench work is hands-on, the team is friendly, and you will get responsibility quickly."
"I appreciate the transparency in R&D updates. They share pipeline wins and setbacks honestly, which makes you feel part of the mission."
"People here care about patient impact, but there are times when deadlines feel relentless. The balance is better in corporate functions than in manufacturing."
These voices reflect what you will hear when asking employees about working at Graviti Pharmaceuticals. Testimonials tend to highlight meaningful work, collaborative teams, and occasional pressure during project milestones.
The company culture at Graviti Pharmaceuticals leans scientific and mission-driven. Colleagues are proud of the research and product work; you will find people who are genuinely motivated by improving patient outcomes. There is an emphasis on data-driven decisions and cross-functional collaboration between R&D, regulatory, and manufacturing. Informal networks and internal forums help newcomers learn quickly, and the culture supports speaking up with ideas. At the same time, the environment can be described as pragmatic rather than flashy — the focus is on getting things done.
Work-life balance at Graviti Pharmaceuticals varies by function. In corporate and administrative roles, you will generally be able to maintain a reasonable schedule and take advantage of flexible hours. In lab, clinical, and manufacturing roles, shifts and project deadlines sometimes require extended hours, especially close to trials or product launches. The company offers flexible scheduling options where possible and encourages staff to use PTO, but on-the-ground reality can be intensive during high-stakes periods.
Job security is moderate to strong for core drug development and manufacturing roles. The company is funded through revenue and partnerships, and it maintains standard industry safeguards such as multiple grants and diversified projects. That said, job security is influenced by the success of clinical trials and regulatory approvals. Positions tied directly to a specific program can be more exposed if that program stalls.
Senior leadership has a background in pharmaceuticals and biotech, with experience in clinical development and commercialization. They communicate quarterly updates and are visible in town halls. Strategic direction is clear in public-facing initiatives and pipeline priorities. Management style is generally methodical and evidence-based, with an emphasis on compliance and quality. There is room for improvement around middle management consistency and cross-team coordination.
Manager experience is mixed. Many managers are praised for being supportive mentors who invest in staff development and provide clear expectations. Some managers are described as micromanaging or slow to delegate, which can create frustration on project teams. Performance feedback tends to be formalized during review cycles, but day-to-day coaching varies by team.
Learning and development at Graviti Pharmaceuticals is solid. The company provides onboarding programs, internal technical workshops, and access to external conferences and scientific meetings. There is a tuition assistance program and a modest L&D budget for most employees. Mentorship programs and cross-functional rotations are available, though not uniformly implemented across all departments.
Promotions tend to follow annual review cycles. There is a clear path for technical growth (e.g., scientist to senior scientist to principal scientist) and management tracks for those who want to lead teams. Career mobility between functions is encouraged, particularly into regulatory and clinical roles, but competition is steady. Those who demonstrate project leadership and publishable results will find promotion opportunities more accessible.
Salary ranges are competitive for the mid-market biotech tier. Typical ranges (USD) are:
Compensation aligns with experience and location, and pharmaceutical industry benchmarks generally match or slightly exceed local averages.
Bonuses and incentives are performance-linked. Annual bonuses typically range from 5% to 15% of base salary for most roles, and higher-level positions may receive larger performance payouts. Equity or stock options are more common for senior hires and key contributors. Incentive plans are tied to company milestones, individual objectives, and, in some cases, clinical or regulatory achievements.
The company provides a comprehensive benefits package including medical, dental, and vision coverage. Health Savings Account (HSA) options, mental health resources, and employee assistance programs are available. Parental leave and short-term disability follow industry standard minimums, and the company offers wellness initiatives such as on-site health screenings and subsidized gym memberships.
Employee engagement is active: town halls, quarterly social events, volunteer days, and science fairs are common. The company sponsors team offsites and holiday gatherings, and it supports participation in industry conferences. These events help build camaraderie and give employees chances to present work across departments.
Remote work support is pragmatic. Corporate and administrative teams often work hybrid (two to three days remote per week), with good collaboration tools and documented processes. Lab-based and manufacturing roles require onsite presence; remote options are limited. The company provides hardware stipends and remote IT support for eligible staff.
Average working hours are around 40–45 hours per week for most corporate employees. In labs and manufacturing, 45–55 hours per week is common during peak phases. Overtime is compensated or managed through time-off policies depending on role and local regulations.
Attrition is moderate, roughly in the high single digits to mid-teens percentage annually, typical for the industry. The company had a modest restructuring about two years ago that affected a small portion of staff (approximately 5%), focused on operational efficiency rather than mass layoffs. There have been no recent large-scale layoffs.
Overall, Graviti Pharmaceuticals is a solid choice for professionals who want meaningful work in a mission-driven environment with competitive pay and benefits. You will find strong technical teams, room for development, and a culture that values scientific rigor. Work-life balance and managerial consistency vary by department, so prospective employees should ask targeted questions during interviews. Overall rating: 4.0 out of 5.
Read authentic experiences from current and former employees at Graviti Pharmaceuticals
Graviti Pharmaceuticals invests in training and hands-on project work. My manager is supportive, and there are regular knowledge-sharing sessions. Flexible hours and hybrid work help balance lab time with paperwork. Good exposure to formulation development.
Decision-making can be slow at times and cross-team coordination has some bureaucracy. Compensation is okay but could be more competitive for senior scientists.
Stable employer with clear SOPs and good safety standards. Graviti Pharmaceuticals has decent shift infrastructure and the site invests in equipment maintenance. Team is experienced and helpful.
Long shifts and frequent overtime during peak production runs. Limited upward mobility for shopfloor roles and promotions are slow. Salary increments are modest compared to workload.
Good product portfolio and scientific backing which helps in field discussions. The regional head was supportive and there were opportunities to learn market strategies. Travel allowance and client perks were reasonable.
Targets were often aggressive and changed frequently during reorganizations. Commission payments sometimes had delays and internal restructuring made role clarity fuzzy. Salary base felt below market for the expectations.
